Status:
COMPLETED
A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi Arabia
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to collect information on how Tresiba® works in real world patients. Patients will get Tresiba® as prescribed to them by their study doctor. The study will last for about 6...
Eligibility Criteria
Inclusion
- Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol)
- The decision to initiate treatment with commercially available Tresiba® has been made by the patient/legally acceptable representative and the treating physician before and independently from the decision to include the patient in this study
- Male or female, age above or equal to 18 years at the time of signing informed consent
- Diagnosed with type 2 diabetes and treated with any antihyperglycaemic medication(s), except Tresiba®, for at least 26 weeks prior to Informed consent and Initiation Visit (Visit 1)
- Available and documented HbA1c value measured within the last 12 weeks prior to initiation of Tresiba® treatment
Exclusion
- Previous participation in this study. Participation is defined as having given informed consent in this study
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Hypersensitivity to the active substance or to any of the excipients as specified in the Tresiba® local label
Key Trial Info
Start Date :
December 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
597 Patients enrolled
Trial Details
Trial ID
NCT03785522
Start Date
December 23 2018
End Date
November 30 2020
Last Update
June 4 2021
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
AL Qateef, Saudi Arabia, 31911
2
Novo Nordisk Investigational Site
Dammam, Saudi Arabia, 32236
3
Novo Nordisk Investigational Site
Dammam, Saudi Arabia, 32253
4
Novo Nordisk Investigational Site
Dammam, Saudi Arabia, 32263